Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469521 · ClinicalTrials.gov registry record · Phase 4
Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00469521: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00469521 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00469521, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.
Interventions
- DRUG Refresh Tears, 9582X
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00469521 record still lists
NCT00469521 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Refresh Tears, 9582X is the first listed.
NCT00469521 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00469521 about?
NCT00469521 is a clinical study titled "Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness". To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.
What is the current status of trial NCT00469521?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00469521?
The interventions under investigation include: Refresh Tears, 9582X (DRUG).
Who is sponsoring clinical trial NCT00469521?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.